Retinal ganglion cells are known to express estrogen receptors and prior studies have suggested an association between postmenopausal hormone (PMH) use and decreased intraocular pressure, suggesting that PMH use may decrease the risk for primary openangleglaucoma (POAG).
IMPORTANCE:
Retinal ganglion cells are known to express estrogen receptors and prior studies have suggested an association between postmenopausal hormone (PMH) use and decreased intraocular pressure, suggesting that PMH use may decrease the risk for primary openangleglaucoma (POAG).
OBJECTIVE:
To determine whether the use of 3 different classes of PMH affects the risk for POAG.
DESIGN, SETTING, AND PARTICIPANTS:
Retrospective longitudinal cohort analysis of claims data from women 50 years or older enrolled in a US managed-care plan for at least 4 years in which enrollees had at least 2 visits to an eye care provider during the period 2001 through 2009. EXPOSURE Postmenopausal hormone medications containing estrogen only, estrogen + progesterone, and estrogen + androgen, as captured from outpatient pharmacy claims over a 4-year period.
MAIN OUTCOMES AND MEASURES:
Hazard ratios (HRs) for developing incident POAG. 
RESULTS:

